CYP2C19 and Stroke: CYP2C19 no function allele carriers receiving clopidogrel had a significantly higher risk of stroke (RR: 1.92, 95% CI: 1.57–2.35) and major vascular events (RR: 1.51, 95% CI: 1.10–2.06) compared to non-carriers (76).